Preclinical molecular imaging technology developer Bioscan has signed a supply agreement with ultrasound vendor Ultrasonix Medical.
Under the deal, Ultrasonix will supply specialized ultrasound imaging products to Bioscan for use in the preclinical imaging market. The preclinical ultrasound imaging systems will be marketed under the BioSonic Wave and BioSonic View brand names.
Bioscan will showcase the systems at this week's World Molecular Imaging Congress (WMIC) in Dublin, Ireland.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
